66
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7

, , , &
Pages 3363-3378 | Published online: 14 Oct 2016

References

  • ChoiKSKimSHKimEOProtection from hemolytic uremic syndrome by eye drop vaccination with modified enterohemorrhagic E. coli outer membranes vesiclesPLoS One20149e10022925032703
  • TarrPIGordonCAChandlerWLShiga-toxin-producing Escherichia coli and haemolytic uraemic syndromeLancet200536594641073108615781103
  • DallmanTJByrneLAshtonPMWhole genome sequencing for national surveillance of Shiga toxin producing Escherichia coli O157Clin Infect Dis201561330531225888672
  • YoonJWHovdeCJAll blood, no stool: enterohemorrhagic Escherichia coli O157 infectionJ Vet Sci2008921923118716441
  • CampbellDMRappoccioloGJenkinsFJRinaldoCRDendritic cells: key players in human herpesvirus 8 infection and pathogenesisFront Microbiol2014545225221546
  • ObrigTGEscherichia coli Shiga toxin mechanism of action in renal diseaseToxins201022769279421297888
  • KimSHLeeYHLeeSHMouse model for hemolytic uremic syndrome induced by outer membrane vesicles of Escherichia coli O157:H7FEMS Immnol Med Microbiol2011633427434
  • GomezSARecaldeMJAPanekCAThe oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndromeClin Exp Immunol2013173346347223607458
  • GrisaruSManagement of hemolytic-uremic syndrome in childrenInt J Nephrol Renovasc Dis2014723123924966691
  • BitzmanMTreatment options for HUS secondary to Escherichia coli O157:H7Kidney Int Suppl200975S62S66
  • BitzanMPooleRMehranMSafety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteersAntimicrob Agents Chemother20095373081308719414580
  • RhodeHQinJCuiYE. coli O104:H4 Genome Analysis Crowd-Sourcing ConsortiumOpen-source genomic analysis of Shiga-toxin–producing E. coli O104:H4N Engl J Med2011365871872421793736
  • McGannonCMFullerCAWeissAADifferent classes of antibiotics differentially influence Shiga toxin productionAntimicrob Agents Chemother20105493790379820585113
  • DundasSToddWTNeillMATarrPIUsing antibiotics in suspected haemolytic-uraemic syndrome: antibiotics should not be used in Escherichia coli O157:H7 infectionBMJ20053301209
  • LosJMLosMWegrzynAWegrzynGAltruism of Shiga toxin-producing Escherichia coli: recent hypothesis versus experimental resultsFront Cell Infect Microbiol2012216623316482
  • KalghatgiSSpinaCSCostelloJCBactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in mammalian cellsSci Transl Med20135192192ra85
  • GomezSAAbrey-RecaldeMJPanekCAThe oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndromeClin Exp Immunol2013173346347223607458
  • PeriloCSPereiraMTSantoroMMNagemRAPStructural binding evidence of the trypanocidal drugs Berenil® and Pentacarinate® active principles to a serine protease modelInt J Biol Macromol20104650251120356563
  • QiYFZhangJColllenTDiminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induces cardiac pathophysiologyHypertension20136274675223959549
  • VelkoskaEPatelSKGriggsKPickeringRJTikellisCBurrellLMShort-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomyPLoS One2015103e011875825786223
  • MalekMNematbakhshMThe preventive effects of diminazene aceturate in renal ischemia/reperfusion injury in male and female ratsAdv Prev Med2014201474064725478235
  • ZhangYLiuJLuoJUpregulation of angiotensin (1-7)-mediated signaling preserves endothelial function through reducing oxidative stress in diabetesAntioxid Redox Signal2015231188089225867182
  • KuriakoseSUzonnaJEDiminazene aceturate (Berenil©), a new use for an old compoundInt Immunopharmacol20142134234524893117
  • CappoenDVajsJUythehtofkenCAnti-mycobacterial activity of 1,3-diaryltriazenesEur J Med Chem20147719320324631899
  • BielawskiKBielawskaAPopławskaBBołkun-SkórnickaUSynthesis, DNA-binding affinity and cytotoxicity of the dinuclear platinum(II) complexes with berenil and amines ligandsActa Pol Pharm200865336337018646556
  • PortugalJBerenil acts as a poison of eukaryotic topoisomerase IIFEBS Lett19943442–31361388187871
  • MeredithAMDassCRIncreasing role of the cancer chemotherapeutic doxorubicinJ Pharm Pharmacol20166872974126989862
  • TaylorJSBeeriKReynoldsJLProphage induction is enhanced and required for renal disease and lethality in an EHEC mouse modelPLoS Pathog201393e10003236
  • WaldorMKFriedmanDIPhage regulatory circuits and virulence gene expressionCurr Opin Microbiol20058445946515979389
  • XiongYWangPLanRA novel Escherichia coli O157:H7 clone causing a major hemolytic uremic syndrome outbreak in ChinaPLoS One201274e3614422558360
  • KangMAnSSAAcetaminophen and its regioisomer, 3-acetamidophenol interfered with the growth of Escherichia coli O157:H7Toxicol Environ Health Sci20102278283
  • DwyerDJBelenkyPAYangJHAntibiotics induce redox-related physiological alterations as part of their lethalityProc Natl Acad Sci U S A201411120E2100E210924803433
  • RamasamyMYiDKAnSSAEnhanced detection sensitivity of Escherichia coli O157:H7 using surface-modified gold nanorodsInt J Nanomedecine201510Spec Iss179190
  • CorcoranJWHahnFEMechanism of Action of Antimicrobial and Antitumor AgentsBerlinSpringer Science & Business Media20123645
  • HornerMGiglioVFSantosAJTriazenos e atividade antibacteriana [Triazenes and antibacterial activity]Rev Bras Cienc Farm [online]2008443441449
  • SchroederCMZhaoCDebRoyCAntimicrobial resistance of Escherichia coli O157 isolated from humans, cattle, swine, and foodAppl Environ Microbiol200268257658111823193
  • VogwillTKojadinovicMMacLeanRCEpistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of PseudomonasProc Biol Sci201628318302016015127170722
  • LainhartWStolfaGKoudelkaGBShiga toxin as bacterial defense against a eukaryotic predator Tetrahymena thermophilaJ Bacteriol200919151125116
  • LicznerskaKNejman-FaleńczykBBlochSOxidative stress in Shiga toxin production by enterohemorrhagic Escherichia coliOxid Med Cell Longev201620168 Article ID 3578368
  • FaleńczykBNGolecPMaciągMWegrzynAWęgrzynGInhibition of development of Shiga toxin-converting bacteriophages by either treatment with citrate or amino acid starvationFoodborne Pathog Dis20129131922047055
  • Martinez-CastilloAMuniesaMImplications of free Shiga toxin-converting bacteriophages occurring outside bacteria for the evolution and the detection of Shiga toxin producing Escherichia coliFront Cell Infect Microbiol201441724478989
  • Diez-GonzalezFRussellJBEffects of carbonylcyanide-m-chlorophenylhydrazone (CCCP) and acetate on Escherichia coli O157:H7 and K-12: uncoupling versus anion accumulationFEMS Microbiol Lett1997151171769198284
  • TylerJSBeeriKReynoldsJLProphage induction is enhanced and required for renal disease and lethality in an EHEC mouse modelPLoS Pathog201393e1003236IsbergRR23555250